(NaturalNews) According to the American Cancer Society (ACS),
breast cancer is the most common cancer in women, affecting over
200,000 women in the U.S. each year and killing more than
40,000. For American men, cancer of the prostate is the type of
malignancy that strikes with the greatest frequency. The ACS
says an estimated 192,280 men will be diagnosed with the disease
in 2009 and around 27,360 men will die from it. Based on the
assumption that finding breast and prostate cancers in the
earliest stages will make them easier to cure and slash
mortality rates, for over twenty years the U.S. medical
establishment has pushed for mass screenings for these common
cancers. So after two decades, all this testing must have
resulted in a huge decline in deaths from these diseases, right?
In an opinion piece published in the October 21st issue of the
Journal of the American Medical Association (JAMA), experts from
the University of California, San Francisco (UCSF) and the
University of Texas (UT) Health Science Cente